Recent Finacing
Recent Raise
Neurocentrx is a clinical-stage biopharma firm developing an abuse-deterrent oral ketamine therapy and companion digital prescription platform for treatment-resistant mood disorders.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Neurocentrx.
